Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07413666
PHASE1

A Study of ORX489 in Healthy Adult Participants, Aged 18 to 60 Years

Sponsor: Centessa Pharmaceuticals (UK) Limited

View on ClinicalTrials.gov

Summary

Characterize the safety, tolerability and pharmacokinetics of ORX489 following single and multiple doses.

Official title: A Safety, Tolerability, Pharmacokinetic, Food Effect, and Proof-of-Concept Study of Single and Multiple Doses of ORX489 in Healthy Adults

Key Details

Gender

All

Age Range

18 Years - 60 Years

Study Type

INTERVENTIONAL

Enrollment

212

Start Date

2026-02-25

Completion Date

2027-06-30

Last Updated

2026-02-25

Healthy Volunteers

Yes

Interventions

DRUG

ORX489 Tablets

ORX489 Tablets

OTHER

Placebo Tablets

Placebo Tablets

Locations (1)

Celerion

Lincoln, Nebraska, United States